A study on management of chronic prostatitis by basti therapy
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 30
- 试验地点
- 1
- 主要终点
- Disease specific subjective parameters based on NIH CPSI score and IIEF 5 Scoring.
研究概览
简要总结
On the basis of previous data and disease prevalence a total sample size of 30 patients has calculated after statistical analysis.Patients with signs and symptoms of chronic prostatitis will be selected from OPD/IPD of department of Shalya Tantra and included in a single interventional group. Complete evaluation will be done by clinical examination, hematological, biochemical, radiological, urine analysis and uroflowmetry studies. Patients wil be treated with Kala Basti for a period of 15 days; 10 anuvasana basti with shilodhbhidadi Taila and 5 kashaya basti with saptaprasratik Kashaya. Before and after completion of therapy patients will be assessed by subjective (NIH CPSI scoring and IIEF 5 scoring ) and objective parameters including radiological findings (USG,TRUS, Multiparametric MRI) and biochemical analysis(Serum PSA and Serum Testosterone) for inflammation of prostate .. The biochemical , biophysical , biosafety , toxicity study and therapeutics of saptaprasritik basti and shilodhbhidadi taila will be studied.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 盲法
- None
入排标准
- 年龄范围
- 20.00 Year(s) 至 40.00 Year(s)（—）
- 性别
- Male
入选标准
- •Age between 20-40yrs All cases of chronic prostatitis /Chronic pelvic pain syndrome Diagnosed cases of sexual dysfunction i.e. ejaculatory pain, erectile dysfunction, premature ejaculation.
- •Patients willing to participate in the study.
排除标准
- •Acute prostatitis Prostatic abscess Pyuria Chronic HTN T2DM Known cases of Systemic disease like Tuberculosis, HepatitisB, HIV, Hepatitis C, Cardiac diseases, Uncontrolled DM Neurogenic bladder Carcinoma of prostate Subjects with ARF&CRF Subjects with Veneral diseases Urethral stricture.
结局指标
主要结局
Disease specific subjective parameters based on NIH CPSI score and IIEF 5 Scoring.
时间窗: Basti will be administered for a period of 15 days followed by follow up at 15 days , 1 month and 2 months .
Objective parameters based on radiological findings (USG,TRUS, Multiparametric MRI) and biochemical analysis(Serum PSA and Serum Testosterone) inflammation of prostate will be assessed.
时间窗: Basti will be administered for a period of 15 days followed by follow up at 15 days , 1 month and 2 months .
次要结局
- Relief in signs and symptoms of chronic prostatitis
研究者
Dr Rohit Kumar Yadav
Banaras Hindu University